维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="VALLERA DA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in mouse xenograft model of B-cell leukemia/lymphoma 显示文摘	VALLERA DA TODHUNTER DA KUROKI DW	2005	Clin Cancer IRes2005，11，10：	1
2	Radioimnmnother- apy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody 显示文摘	Vallera DA Brechbiel MW Burns LJ	2005	Clin Cancer Res2005，11，21：	1
3	Targeting myeloid leukemia with a DT sub(390)-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice显示文摘	Vallera DA Seo S Y Panoskaltsis MA	1999	Protein Eng1999，12，9：	1
4	A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma 显示文摘	Vallera DA Todhunter DA Kuroki DW	2005	Clin Cancer Res2005，11，10：	1
5	Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody显示文摘	Vallera DA Elson M Brechbiel MW	2004	Cancer Biother Radiopharm2004，19，1：	1
6	B lymphocyte regulation of human hematopoiesis 显示文摘	Uckun FM Vallera DA Wee S	1985	Immunol1985，135，6：	1
7	Molecular modification of a recombinant,bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice显示文摘	Vallera DA Todhunter D Kuroki DW	2005	Leuk Res2005，29，3：	1
8	Targeting myeloid leu- kemia with fl DT sub (390)-rolL-3 fusion immunotoxin: ex vivo and in vivo studies in mice 显示文摘	Vallera DA Seo SY Panoskaltsis MA	1999	Protein Eng1999，12，9：	1
9	Recent advances in graft-versus-host disease prevention显示文摘	Korngold R Vallera DA	1997	Immunol Rev1997，157，：	1
10	A bispecific recombinant immunotoxin,DT2219,targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma显示文摘	Vallera DA Todhunter DA	2005	Clin Cancer Res2005，11，10：	1
11	Bone manorrow transplantation across major histo computibility barriers in mice显示文摘	Vallera DA Sodevling CCB Carlson GJ	1981	Transplantation1981，31，2：	1
12	显示文摘	Vallera DA Kuroki DW Panoskaltsis-Mortari A	2000	Blood2000，96，3：	1
13	Recent advances in graft-versus-host-disease (GVHD) prevention显示文摘	Blazar BR Komgold R Vallera DA	1997	Immunol Rev1997，157，：	1
14	Renal dysfunctionaccounts for the dose limiting toxicity of DT390 anti-CD3sFv, apotential new recombinant anti- GVHD immunotoxin显示文摘	Vallera DA Panoskaltsis-Mortafi A Blazar BR	1997	Protein Eng1997，10，9：	1
15	Adult bone marrow-derived pluripotent hematopoietic stem cells are engrafiable when transferred in utero into moderately anemic fetal recipients显示文摘	Blazar BR Taylor PA Vallera DA	1995	Blood1995，85，3：	1
16	Molecularmodification ofa recombinant anti -CD3 epsilon -directed immunotoxinby inducing terminal cysteine bridging enhances anti- GVHD efficacyand reduces organ toxicity in a lethal murine model显示文摘	Vallera DA Kuroki DW Panoskaltsis- Mortari A	2000	Blood2000，96，3：	1
17	Immunotoxin therapy for CNS tumor显示文摘	Rustamzadeh E Low WC Vallera DA	2003	J Neurooncol2003，64，12：	1
18	Targeting urokinase-type plasminogenactivator receptor on human glioblastoma tumors with diphtheria toxinfusion protein DTAT显示文摘	Vallera DA Li C Jin N	2002	J Natl Cancer Inst2002，94，8：	1
19	CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients显示文摘	Blazar BR Taylor PA Vallera DA	1997	Transplantation1997，64，：	1
20	CD4^+ and CD8^+ T cells each can utilize a perforin-dependeat pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients 显示文摘	Blazar BR Taylor PA Vallera DA	1997	Transplantation1997，64，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示